tiprankstipranks
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market
GLMD
Galmed Pharmaceuticals
RESEARCH TOOLSreports

Galmed Pharmaceuticals (GLMD) Financial Statements

1,310 Followers

Galmed Pharmaceuticals Financial Overview

Galmed Pharmaceuticals's market cap is currently $4.89M. The company's EPS TTM is $-0.33; its P/E ratio is -0.31; Galmed Pharmaceuticals is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -83.00K$ -31.00K$ -35.00K$ -42.00K
Operating Income$ -8.51M$ -6.28M$ -7.49M$ -17.65M$ -32.88M
EBITDA$ -8.51M$ -6.20M$ -7.46M$ -17.62M$ -32.84M
Net Income$ -10.31M$ -7.52M$ -6.91M$ -17.87M$ -32.47M
Balance Sheet
Cash & Short-Term Investments$ 18.16M$ 15.33M$ 12.64M$ 13.79M$ 34.81M
Total Assets$ 18.63M$ 18.50M$ 16.63M$ 16.56M$ 36.60M
Total Debt$ 0.00$ 0.00$ 41.00K$ 215.00K$ 229.00K
Net Debt$ -3.98M$ -4.65M$ -2.82M$ -1.80M$ -2.65M
Total Liabilities$ 2.85M$ 2.17M$ 2.75M$ 3.14M$ 6.11M
Stockholders' Equity$ 15.78M$ 16.33M$ 13.88M$ 13.42M$ 30.50M
Cash Flow
Free Cash Flow$ -6.32M$ -5.88M$ -6.14M$ -18.50M$ -32.90M
Operating Cash Flow$ -6.32M$ -5.88M$ -6.14M$ -18.50M$ -32.89M
Investing Cash Flow$ -3.38M$ -1.11M$ 800.00K$ 17.56M$ 11.46M
Financing Cash Flow$ 9.03M$ 8.79M$ 6.18M$ 70.00K$ 17.37M
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History

Income Statement >

Galmed Pharmaceuticals Debt to Assets

Balance Sheet >

Galmed Pharmaceuticals Cash Flow

Cash Flow >

Galmed Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >